期刊文献+

不同类型肿瘤抗原致敏的树突状细胞体外诱导前列腺癌特异性CTL的研究 被引量:1

Induction of prostate cancer-specific CTLs with dendritic cells pulsed by different types of tumor antigens
下载PDF
导出
摘要 目的:研究肿瘤冻融抗原及弱酸洗脱提取的肿瘤抗原肽分别冲击致敏树突状细胞(dendritic cells,DCs)体外诱导前列腺癌特异性细胞毒性T淋巴细胞(CTL)的效应。方法:采用反复冻融法和弱酸洗脱法,分别获取前列腺癌细胞株PC-3的肿瘤抗原,应用重组人GM-CSF、IL-4体外培养诱导外周血单个核细胞获得DC,并分别负载两种前列腺癌肿瘤抗原,检测其体外激活肿瘤特异性CTL的能力,用LDH释放法检测其对PC-3的体外杀伤效应。结果:用枸橼酸-磷酸盐缓冲液洗脱或反复冻融PC-3(2×107)后获得的肿瘤抗原蛋白含量分别为(312.2±7.9)μg和(963.0±25.3)μg,负载两种前列腺癌细胞抗原的DCs致敏的CTL对PC-3细胞有明显的杀伤作用,而且负载弱酸洗脱提取的肿瘤抗原肽的DCs致敏的特异性CTL具有更明显的杀伤作用[(60.4±5.52)%vs(43.7±4.11)%,P<0.01)]。结论:弱酸洗脱和反复冻融方法都可以有效获取前列腺癌抗原,用于体外致敏DCs后,均具有活化CTL的能力,而且弱酸洗脱提取的肿瘤抗原肽更为有效。 Objective:To study the effectiveness of freeze-thaw antigens and acid eluted peptide antigens extracted from tumor cell-pulsed dendritic cells (DC) in inducing prostate cancer-specific cytotoxic T lymphocytes (CTL) in vitro.Methods:Tumor antigens were extracted from the prostate cancer cell line PC-3 with the repeated freeze-thaw and weak acid elution methods.Peripheral blood mononuclear cells were cultured with recombinant human GM-CSF and IL-4 for inducing DCs in vitro.Then the DCs were pulsed with the two kinds of prostate cancer tumor antigens respectively and cultured with T cells for inducing CTLs.The activity of the tumor-specific CTLs were detected by LDH release assay.Results:The protein content in the tumor antigens obtained from PC-3 (2 × 107) by citric acid-phosphate buffer elution and that by the repeated freeze-thaw method were (212.2 ± 7.9) μg and (963.0 ± 25.3) μg,respectively.The two kinds of prostate cancer antigens-pulsed DCs had a significant role in inducing the PC-3 cell-specific CTLs,and the CTLs induced by acid-eluted peptide antigen-pulsed DCs exhibited an even more significant tumor-specific cytotoxicity than those induced by repeated freeze-thaw ([60.4 ± 5.52]% vs [43.7 ± 4.11]%,P0.01).Conclusion:Both the weak acid elution and repeated freeze-thaw methods for extracting prostate cancer antigens can be used for in vitro sensitization of DCs.The DCs pulsed by either of the two kinds of antigens can activate CTLs,and the antigens extracted by weak acid elution are even more effective.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2010年第5期410-414,共5页 National Journal of Andrology
基金 国家自然科学基金(30901716)~~
关键词 肿瘤抗原 树突状细胞 细胞毒性T淋巴细胞 免疫治疗 前列腺癌 tumor antigen dendritic cell cytotoxic T lymphocyte immunotherapy prostate cancer
  • 相关文献

参考文献10

  • 1Melief CJ. Cancer immunotherapy by dendritic cells. Immunity, 2008, 29(3): 372-383.
  • 2Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: Moving beyond current vaccines . Nat Med, 2004,10(9) : 909- 915.
  • 3金建军,张元芳.树突状细胞与泌尿系肿瘤免疫治疗研究进展[J].国外医学(泌尿系统分册),2000,20(2):64-66. 被引量:9
  • 4Hamada I. A clinical study on tumor-associated monocyte lineage ceils in renal cell carcinoma. Hinyokika Kiyo, 2002, 48 (4) : 213-220.
  • 5Nouri-Shirazi M, Banehereau J, Bell D, et al . Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J Immunol, 2000, 165 (7): 3797-3803.
  • 6Storkus WJ, Zeh HJ 3rd, Salter RD, et al. Identification of T- cell epitopes: Rapid isolation of class I-presented peptides from viable ceils by mild acid elution. J Immunother Emphasis Tumor Immunol, 1993, 14(2) : 94-103.
  • 7齐士勇,王萌,徐勇.前列腺癌组织中树突状细胞的变化及以此为基础的免疫治疗[J].中华男科学杂志,2007,13(5):453-456. 被引量:4
  • 8Kiessling A, Fussel S, Wehner R, et al. Advances in specific immunotherapy for prostate cancer. Eur Urol, 2008, 53 (4) : 694 -708.
  • 9Elzey BD, Siemens DR, Ratliff TL, et al. Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (ALVAC) cytokine gene deli- very induces destruction of established prostate tumors. Int J Cancer, 2001,94 (6): 842-849.
  • 10Pandha HS, John R J, Hutchinson J, et al. Dendritic cell immunotherapy for urological cancers using cryoprcserved allogenic tumor lysate-pulscd cells: A phase I/II study. BJU International, 2004, 94(3) : 412-418.

二级参考文献32

  • 1Shurin MR,Lu L,Kalinski P,et al.Th1/Th2 balance in cancer,transplantation and pregnancy[J].Springer Semin Immunopathol,1999,21(3):339-359.
  • 2Ho CS,Lopez JA,Vuckovic S,et al.Surgical and physical stress increases circulating blood dendritic cell counts independently of monocyte counts[J].Blood,2001,98(1):140-145.
  • 3Burch PA,Breen JK,Buckner JC,et al.Priming tissue-specific cellular immunity in a phase Ⅰ trial of autologous dendritic cells for prostate cancer[J].Clin Cancer Res,2000,6(6):2175-2182.
  • 4Triozzi PL,Khurram R,Aldrich WA,et al.Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer[J].Cancer,2000,89(12):2646-2654.
  • 5Murphy G,Tjoa B,Ragde H,et al.Phase Ⅰ clinical trial:T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen[J].Prostate,1996,29(6):371-380.
  • 6Tjoa BA,Lodge PA,Salgaller ML,et al.Dendritic cell-based immunotherapy for prostate cancer[J].CA Cancer J Clin,1999,49(2):117-128.
  • 7Small EJ,Fratesi P,Reese DM,et al.Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells[J].J Clin Oncol,2000,18(23):3894-3903.
  • 8Fong L,Brockstedt D,Benike C,et al.Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy[J].J Immunol,2001,167(12):7150-7156.
  • 9Heiser A,Coleman D,Dannull J,et al.Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors[J].J Clin Invest,2002,109(3):409-417.
  • 10Vonderheide RH,Domchek SM,Schultze JL,et al.Vaccination of cancer patients against telomerase induces functional antitumor CD+8 T lymphocytes[J].Clin Cancer Res,2004,10(3):828-839.

共引文献11

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部